ArticleEndocrine, metabolic & immune disorders drug targets2024

Hypophysitis Induced by Sintilimab in the Treatment of Bladder Cancer: A Case Report.

Ran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.